Global Home Infusion Therapy market analysis 2024, Forecast To 2033

The home infusion therapy market has undergone rapid growth, increasing from $28.68 billion in 2023 to $31.95 billion in 2024, with a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period is attributed to an aging population, a rise in patient preference for home-based care, increased prevalence of chronic diseases, and a surge in hospital avoidance. Expected to experience rapid growth in the next few years, the market is projected to reach $47.43 billion in 2028, with a CAGR of 10.4%. The forecasted growth is linked to the rising integration of telehealth services, increasing adoption of personalized medicine, a surge in pandemic preparedness, patient empowerment initiatives, and the growing popularity of value-based care models. Key trends in the forecast period include the adoption of advanced infusion devices, a focus on biologic and specialty drugs, the expansion of pediatric home infusion, ensuring infusion pump safety, and robust patient education and training.